Boston Partners Has $3.28 Million Position in Walgreens Boots Alliance Inc (WBA)

Share on StockTwits

Boston Partners cut its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 98.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,897 shares of the pharmacy operator’s stock after selling 3,922,047 shares during the period. Boston Partners’ holdings in Walgreens Boots Alliance were worth $3,284,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Colony Group LLC grew its stake in Walgreens Boots Alliance by 2.3% in the fourth quarter. Colony Group LLC now owns 6,142 shares of the pharmacy operator’s stock valued at $420,000 after acquiring an additional 141 shares during the period. Covington Capital Management grew its stake in Walgreens Boots Alliance by 11.1% in the fourth quarter. Covington Capital Management now owns 1,500 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 150 shares during the period. Barnett & Company Inc. grew its stake in Walgreens Boots Alliance by 11.1% in the fourth quarter. Barnett & Company Inc. now owns 1,501 shares of the pharmacy operator’s stock valued at $103,000 after acquiring an additional 150 shares during the period. Focused Wealth Management Inc grew its stake in Walgreens Boots Alliance by 10.1% in the fourth quarter. Focused Wealth Management Inc now owns 1,651 shares of the pharmacy operator’s stock valued at $113,000 after acquiring an additional 151 shares during the period. Finally, Mission Wealth Management LP grew its stake in Walgreens Boots Alliance by 5.9% in the fourth quarter. Mission Wealth Management LP now owns 3,124 shares of the pharmacy operator’s stock valued at $213,000 after acquiring an additional 175 shares during the period. 64.77% of the stock is owned by hedge funds and other institutional investors.

In related news, COO Ornella Barra bought 18,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 3rd. The shares were acquired at an average price of $54.56 per share, for a total transaction of $982,080.00. Following the completion of the acquisition, the chief operating officer now owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the sale, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The disclosure for this sale can be found here. Corporate insiders own 15.73% of the company’s stock.

A number of research analysts have issued reports on the company. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Friday, March 29th. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Friday, March 29th. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, April 13th. Pivotal Research reduced their price objective on Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Finally, Mizuho set a $67.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Thursday, March 28th. Five research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $68.00.

WBA stock opened at $52.74 on Thursday. Walgreens Boots Alliance Inc has a fifty-two week low of $51.79 and a fifty-two week high of $86.31. The stock has a market cap of $47.65 billion, a PE ratio of 8.76, a PEG ratio of 1.06 and a beta of 0.77. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The company had revenue of $34.53 billion for the quarter, compared to the consensus estimate of $34.57 billion. During the same quarter in the previous year, the company posted $1.73 EPS. The business’s revenue was up 4.6% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, May 17th. This represents a $1.76 annualized dividend and a yield of 3.34%. Walgreens Boots Alliance’s payout ratio is presently 29.24%.

TRADEMARK VIOLATION WARNING: This report was first published by Macon Daily and is owned by of Macon Daily. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://macondaily.com/2019/05/16/boston-partners-has-3-28-million-position-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: What do investors mean by earnings per share?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.